BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29794097)

  • 1. Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.
    Alwhaibi M; Balkhi B; Alhawassi TM; Alkofide H; Alduhaim N; Alabdulali R; Drweesh H; Sambamoorthi U
    BMJ Open; 2018 May; 8(5):e020852. PubMed ID: 29794097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
    Moore HN; Mao L; Oramasionwu CU
    AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy and comorbidities among ambulatory cancer patients: A cross-sectional retrospective study.
    Alwhaibi M; AlRuthia Y; Alhawassi TM; Almalag H; Alsalloum H; Balkhi B
    J Oncol Pharm Pract; 2020 Jul; 26(5):1052-1059. PubMed ID: 31619132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Factors Associated With Polypharmacy Use Among Adult Patients in Saudi Arabia.
    Balkhi B; AlQahtani N; Alwhaibi M; Alshammari TM; Alhawassi TM; Mahmoud MA; Almetwazi M; Ata S; Basyoni M; Aljadhey H
    J Patient Saf; 2021 Dec; 17(8):e1119-e1124. PubMed ID: 29087978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.
    Balkhi B; Alwhaibi M; Alqahtani N; Alhawassi T; Alshammari TM; Mahmoud M; Almetwazi M; Ata S; Kamal KM
    BMJ Open; 2019 Jul; 9(7):e029280. PubMed ID: 31340969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of polypharmacy in heart failure patients: A retrospective cross-sectional study in a tertiary hospital in Saudi Arabia.
    Alsultan MM; Alamer R; Alammar F; Alzlaiq W; Alahmari AK; Almalki ZS; Alqarni F; Alshayban DM; Alotaibi FM; Asiri IM; Alsultan F; Kurdi SM; Almalki BA
    Saudi Pharm J; 2023 Dec; 31(12):101875. PubMed ID: 38046462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underuse of indicated medications among physically frail older US veterans at the time of hospital discharge: results of a cross-sectional analysis of data from the Geriatric Evaluation and Management Drug Study.
    Wright RM; Sloane R; Pieper CF; Ruby-Scelsi C; Twersky J; Schmader KE; Hanlon JT
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):271-80. PubMed ID: 19948303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using electronic medical record data to characterize the level of medication use by age-groups in a network of primary care clinics.
    Freund J; Meiman J; Kraus C
    J Prim Care Community Health; 2013 Oct; 4(4):286-93. PubMed ID: 24327665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspective.
    Sutaria A; Liu L; Ahmed Z
    Ther Adv Cardiovasc Dis; 2016 Aug; 10(4):242-50. PubMed ID: 26920372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital.
    Tefera YG; Alemayehu M; Mekonnen GB
    PLoS One; 2020; 15(6):e0234000. PubMed ID: 32479516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of polypharmacy prescription among type 2 diabetes patients at a tertiary care department in Ningbo, China: A retrospective database study.
    Li J; Chattopadhyay K; Xu M; Chen Y; Hu F; Wang X; Li L
    PLoS One; 2019; 14(7):e0220047. PubMed ID: 31314797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Multi-Morbidities and Polypharmacy Among Older Adults at an Academic Medical Center in Saudi Arabia.
    AlAbdulKader A; Alsheikh S; Alghamdi R; AlHarkan K; AlShamlan N; Alqahtani H; Awad FA; Alotaibi R
    Med Arch; 2023; 77(6):471-476. PubMed ID: 38313108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the epidemiology of medication errors in adults in community care settings. A retrospective cohort study in central Saudi Arabia.
    Assiri GA; Alkhenizan AH; Al-Khani SA; Grant LM; Sheikh A
    Saudi Med J; 2019 Feb; 40(2):158-167. PubMed ID: 30723861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of polypharmacy and the association with non-communicable diseases in Qatari elderly patients attending primary healthcare centers: A cross-sectional study.
    Al-Dahshan A; Al-Kubiasi N; Al-Zaidan M; Saeed W; Kehyayan V; Bougmiza I
    PLoS One; 2020; 15(6):e0234386. PubMed ID: 32525902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia.
    Batais MA; Schantter P
    Prim Care Diabetes; 2016 Dec; 10(6):415-424. PubMed ID: 27297805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database.
    Ruzicka DJ; Imai K; Takahashi K; Naito T
    BMJ Open; 2018 Jun; 8(6):e019985. PubMed ID: 29903786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of number of drugs prescribed on the risk of potentially inappropriate medication among outpatient older adults with chronic diseases.
    Weng MC; Tsai CF; Sheu KL; Lee YT; Lee HC; Tzeng SL; Ueng KC; Chen CC; Chen SC
    QJM; 2013 Nov; 106(11):1009-15. PubMed ID: 23836694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity-Polypharmacy Score as Predictor of Outcomes in Older Trauma Patients: A Retrospective Validation Study.
    Mubang RN; Stoltzfus JC; Cohen MS; Hoey BA; Stehly CD; Evans DC; Jones C; Papadimos TJ; Grell J; Hoff WS; Thomas P; Cipolla J; Stawicki SP
    World J Surg; 2015 Aug; 39(8):2068-75. PubMed ID: 25809063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy and specific comorbidities in university primary care settings.
    Aubert CE; Streit S; Da Costa BR; Collet TH; Cornuz J; Gaspoz JM; Bauer D; Aujesky D; Rodondi N
    Eur J Intern Med; 2016 Nov; 35():35-42. PubMed ID: 27289492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.
    Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT;
    J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.